<DOC>
	<DOCNO>NCT02016846</DOCNO>
	<brief_summary>Glucocorticoids therapy expose patient increase risk diabetes morbidity . However , proven preventive therapy . GLP-1-RA show improve glucose metabolism healthy volunteer treat glucocorticoid . We assume GLP-1-RA improve glucose metabolism patient high risk diabetes morbidity , treat glucocorticoid .</brief_summary>
	<brief_title>Liraglutide Efficacy Glucocorticoid Induced Hyperglycemia Patients High Risk Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Inclusion criterion : Planned treatment T. Prednisone dosage &gt; 0.5 mg/kg two week . Age &gt; 18 year Body mass index &gt; 27 kg/m2 OR 1st degree relative type 2 diabetes mellitus OR hypertension OR hyperlipidemia OR gestational diabetes past OR diagnosis polycystic ovary syndrome . Exclusion criterion : Glycosylated hemoglobin A1c &gt; 6.5 % Diagnosis diabetes mellitus treatment antiglycemic drug Pancreatitis ( acute chronic ) past Active malignancy Medullary thyroid carcinoma multiple endocrine neoplasm type 2 patient 1st degree relative Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>